[1. Tian Z, van Velkinburgh JC, Wu Y, Ni B. Innate lymphoid cells involve in tumourigenesis. Int J Cancer. 2015; doi: 10.1002/ijc.29443.10.1002/ijc.2944325604320]Search in Google Scholar
[2. Fuchs A, Colonna M. Innate lymphoid cells in homeostasis, infection, chronic inflammation and tumours of the gastrointestinal tract. Curr Opin Gastroenterol 2013; 29: 581-7.10.1097/MOG.0b013e328365d33924100718]Search in Google Scholar
[3. Constantinides MG, McDonald BD, Verhoef PA, Bendelac A. A committed precursor to innate lymphoid cells. Nature 2014; 508: 397-401.10.1038/nature13047400350724509713]Search in Google Scholar
[4. Spits H, Artis D, Colonna M et al. Innate lymphoid cells- a proposal for uniform nomenclature. Nat Rev Immunol 2013; 13: 145-9.10.1038/nri336523348417]Search in Google Scholar
[5. Montaldo E, Vacca P, Moretta L, Mingari MC. Development of human natural killer cells and other innate lymphoid cells. Semin Immunol 2014; 26: 107-13.10.1016/j.smim.2014.01.00624559836]Search in Google Scholar
[6. Yagi R, Zhong C, Northrup DL et al. The transcription factor GATA3 is critical for the development of all IL-7Ralpha-expressing innate lymphoid cells. Immunity 2014; 40: 378-88.10.1016/j.immuni.2014.01.012402679724631153]Search in Google Scholar
[7. Spits H, Di Santo JP. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodelling. Nat Immunol 2011; 12: 21-7.10.1038/ni.196221113163]Search in Google Scholar
[8. Jovanovic I, Pejnovic N, Radosavljevic G et al. Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoural accumulation of immunosuppressive and innate lymphoid cells. Int J Cancer 2013; 134: 1669-82.10.1002/ijc.2848124105680]Search in Google Scholar
[9. Liu J, Duan Y, Cheng X et al. IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma. Biochem Biophys Res Commun 2011; 407: 348-54.10.1016/j.bbrc.2011.03.02121396350]Search in Google Scholar
[10. Kirchberger S, Royston DJ, Boulard O et al. Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model. J Exp Med 2013; 210: 917-31.10.1084/jem.20122308364649423589566]Search in Google Scholar
[11. Ikutani M, Yanagibashi T, Ogasawara M et al. Identification of innate IL-5-producing cells and their role in lung eosinophil regulation and antitumour immunity. J Immunol 2012; 188: 703-13.10.4049/jimmunol.110127022174445]Search in Google Scholar
[12. Moro K, Yamada T, Tanabe M et al. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 2010; 463 (7280): 540-4.10.1038/nature0863620023630]Search in Google Scholar
[13. Saenz SA, Siracusa MC, Perrigoue JG et al. IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses. Nature. 2010; 464: 1362-6.10.1038/nature08901286173220200520]Search in Google Scholar
[14. Neill DR, Wong SH, Bellosi A et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature. 2010; 464(7293): 1367-70.10.1038/nature08900286216520200518]Search in Google Scholar
[15. Hurst SD, Muchamuel T, Gorman DM et al. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J Immunol. 2002; 169: 443-53.10.4049/jimmunol.169.1.44312077275]Search in Google Scholar
[16. Chang YJ, Kim HY, Albacker LA et al. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol. 2011; 12: 631-8.10.1038/ni.2045341712321623379]Search in Google Scholar
[17. Halim TY, Krauss RH, Sun AC, Takei F. Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation. Immunity 2012; 36: 451-63.10.1016/j.immuni.2011.12.02022425247]Search in Google Scholar
[18. Bartemes KR, Iijima K, Kobayashi T, Kephart GM, McKenzie AN, Kita H. IL-33-responsive lineage-CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs. J Immunol 2012; 188: 1503-13.10.4049/jimmunol.1102832326287722198948]Search in Google Scholar
[19. Barlow JL, Bellosi A, Hardman CS et al. Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity. J Allergy Clin Immunol 2012; 129: 191-8.10.1016/j.jaci.2011.09.04122079492]Search in Google Scholar
[20. Kim HY, Chang YJ, Subramanian S et al. Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity. J Allergy Clin Immunol 2012; 129: 216-27.10.1016/j.jaci.2011.10.036324606922119406]Search in Google Scholar
[21. Yasuda K, Muto T, Kawagoe T et al. Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice. Proc Natl Acad Sci U S A. 2012; 109: 3451-6.10.1073/pnas.1201042109329528722331917]Search in Google Scholar
[22. Wilhelm C, Hirota K, Stieglitz B et al. An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nat Immunol 2011; 12: 1071-7.10.1038/ni.2133319884321983833]Search in Google Scholar
[23. Monticelli LA, Sonnenberg GF, Abt MC et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 2011; 12: 1045-54.10.1038/ni.2131]Search in Google Scholar
[24. Mirchandani AS, Salmond RJ, Liew FY. Interleukin-33 and the function of innate lymphoid cells. Trends Immunol 2012; 33: 389-96.10.1016/j.it.2012.04.00522609147]Search in Google Scholar
[25. Kiessling, R. Klein, E., Pross, H. & Wigzell, H. “Natural” killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukaemia cells. Characteristics of the killer cell. Eur. J. Immunol. 1975; 5: 117-121.]Search in Google Scholar
[26. Vonarbourg C, Mortha A, Bui VL et al. Regulated expression of nuclear receptor RORγt confers distinct functional fates to NK cell receptor-expressing RORγt+ innate lymphocytes. Immunity 2010; 33: 736-75110.1016/j.immuni.2010.10.017304272621093318]Search in Google Scholar
[27. Bernink JH, Peters CP, Munneke M et al. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat Immunol. 2013; 14: 221-9.10.1038/ni.253423334791]Search in Google Scholar
[28. Klose CS, Flach M, Möhle L et al. Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell 2014; 157: 340–56.10.1016/j.cell.2014.03.03024725403]Search in Google Scholar
[29. Maloy KJ, Uhlig HH. ILC1 populations join the border patrol. Immunity 2013; 38: 630-2.10.1016/j.immuni.2013.03.00523601681]Search in Google Scholar
[30. Cella M, Fuchs A, Vermi W et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009; 457: 722-725.10.1038/nature07537377268718978771]Search in Google Scholar
[31. Takayama T, Kamada N, Chinen H et al. Imbalance of NKp44(þ)NKp46(−) and NKp44(−) NKp46(þ) natural killer cells in the intestinal mucosa of patients with Crohn’s disease. Gastroenterology 2010; 139: 882-89210.1053/j.gastro.2010.05.04020638936]Search in Google Scholar
[32. Cella M, Otero K, Colonna M. Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity. Proc Natl Acad Sci USA 2010; 107: 10961-10966.10.1073/pnas.1005641107]Search in Google Scholar
[33. Geremia A, Arancibia-Cárcamo CV, Fleming MP et al. IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J Exp Med 2011; 208:1127-1133.10.1084/jem.20101712]Search in Google Scholar
[34. Cupedo T, Crellin NK, Papazian N et al. Human foetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat Immunol 2009; 10: 66-74.10.1038/ni.1668]Search in Google Scholar
[35. Ivanov II, Diehl GE, Littman DR. Lymphoid tissue inducer cells in intestinal immunity. Curr Top Microbiol Immunol 2006; 308: 59-82.10.1007/3-540-30657-9_3]Search in Google Scholar
[36. Takatori H, Kanno Y, Watford WT et al. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med 2009; 206: 35-41.10.1084/jem.20072713]Search in Google Scholar
[37. Hepworth MR, Monticelli LA, Fung TC et al. Innate lymphoid cells regulate T-cell responses to intestinal commensal bacteria. Nature 2013; 498: 113-117.10.1038/nature12240]Search in Google Scholar
[38. Plunkett TA, Correa I, Miles DW and Taylor-Papadimitriou J. Breast cancer and the immune system: opportunities and pitfalls. J. Mammary Gland Biol. Neoplasia 2001. 6: 467–475.10.1023/A:1014743232598]Search in Google Scholar
[39. Ito N, Nakamura H, Tanaka Y and Ohgi S. Lung carcinoma: analysis of T-helper type 1 and 2 cells and T-cytotoxic type 1 and 2 cells by intracellular cytokine detection with flow cytometry. Cancer 1999. 85: 2359–2367.10.1002/(SICI)1097-0142(19990601)85:11<2359::AID-CNCR10>3.0.CO;2-A]Search in Google Scholar
[40. Nishimura T, Nakui M, Sato M et al. The critical role of Th1-dominant immunity in tumour immunology. Cancer Chemother. Pharmacol. 2000. 46: 52–61.10.1007/PL00014051]Search in Google Scholar
[41. Dobrzanski MJ, Reome JB, Hylindand JC and Rewers-Felkins KA. CD8 mediated type 1 antitumour responses selectively modulate endogenous differentiated and nondifferentiated t cell localization, activation, and function in progressive breast cancer. J. Immunol. 2006. 177: 8191–8201.10.4049/jimmunol.177.11.8191]Search in Google Scholar
[42. Vujanovic NL, Basse P, Herberman RB and Whiteside TL. Antitumour functions of natural killer cells and control of metastasis. Methods 1996. 9: 394–408.10.1006/meth.1996.00448812692]Search in Google Scholar
[43. Hung K, Hayashi R, Lafond-Walker A, Lowenstein C, Pardoll D and Levitsky H. The central role of CD41 T cells in the antitumour immune response. J. Exp. Med. 1998. 188: 2357–2368.10.1084/jem.188.12.235722124349858522]Search in Google Scholar
[44. Ellyard JI, Simson L, Parish CR. Th2-mediated antitumour immunity: friend or foe? Tissue Antigens 2007. 70: 1–11.10.1111/j.1399-0039.2007.00869.x17559575]Search in Google Scholar
[45. Stout RD and Bottomly K. Antigen-specific activation of effector macrophages by IFN-g producing (TH1) T cell clones. Failure of IL-4-producing (TH2) T cell clones to activate effector function of macrophages. J. Immunol. 1989. 142: 760–765.10.4049/jimmunol.142.3.760]Search in Google Scholar
[46. Hu HM, Urba WJ and Fox BA. Gene-modified tumour vaccine with therapeutic potential shifts tumour-specific T cell response from a type 2 to a type 1 cytokine profile. J. Immunol. 1998; 161: 3033-3041.]Search in Google Scholar
[47. Akbari O, DeKruyff RH, Umetsu DT. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2001; 2: 725-31.10.1038/9066711477409]Search in Google Scholar
[48. Guedez L, Jensen-Taubman S, Bourboulia D et al. TIMP-2 targets tumour-associated myeloid suppressor cells with effects in cancer immune dysfunction and angiogenesis. J Immunother 2012; 35: 502-12.10.1097/CJI.0b013e3182619c8e340208722735808]Search in Google Scholar
[49. Koyasu S, Moro K. Type 2 innate immune responses and the natural helper cell. Immunology 2011; 132: 475-81.10.1111/j.1365-2567.2011.03413.x307550121323663]Search in Google Scholar
[50. Gabitass RF, Annels NE, Stocken DD et al. Elevated myeloid-derived suppressor cells in pancreatic, oesophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13. Cancer Immunol Immunother 2011; 60: 1419-30.10.1007/s00262-011-1028-0317640621644036]Search in Google Scholar
[51. Li J, Razumilava N, Gores GJ et al. Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation. J Clin Invest 2014; 124: 3241-51.10.1172/JCI73742407137024892809]Search in Google Scholar
[52. Patman G. Biliary tract. IL-33, innate lymphoid cells and IL-13 are required for cholangiocyte proliferation. Nat Rev Gastroenterol Hepatol 2014; 11: 456.10.1038/nrgastro.2014.10124935421]Search in Google Scholar
[53. Pearson C, Uhlig HH, Powrie F. Lymphoid microenvironments and innate lymphoid cells in the gut. Trends Immunol 2012; 33: 289-96.10.1016/j.it.2012.04.00422578693]Search in Google Scholar
[54. Chan IH, Jain R, Tessmer MS et al. Interleukin-23 is sufficient to induce rapid de novo gut tumourigenesis, independent of carcinogens, through activation of innate lymphoid cells. Mucosal Immunol 2014; 7: 842-56.10.1038/mi.2013.10124280935]Search in Google Scholar
[55. Murugaiyan G, Saha B. Protumour vs antitumour functions of IL-17. J Immunol 2009; 183: 4169-75.10.4049/jimmunol.090101719767566]Search in Google Scholar
[56. Kamanaka M, Huber S, Zenewicz LA, et al. Memory/effector (CD45RB(lo)) CD4 T cells are controlled directly by IL-10 and cause IL-22-dependent intestinal pathology. J Exp Med 2011; 208: 1027-40.10.1084/jem.20102149309234421518800]Search in Google Scholar
[57. Brand S, Beigel F, Olszak T, et al. IL-22 is increased in active Crohn’s disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am J Physiol Gastrointest Liver Physiol 2006; 290: 827-38.10.1152/ajpgi.00513.200516537974]Search in Google Scholar
[58. Vonarbourg C, Mortha A, Bui VL et al. Regulated expression of nuclear receptor RORgammat confers distinct functional fates to NK cell receptor-expressing RORgammat(+) innate lymphocytes. Immunity 2010; 33: 736-51.10.1016/j.immuni.2010.10.017304272621093318]Search in Google Scholar
[59. Lim C, Savan R. The role of the IL-22/IL-22R1 axis in cancer. Cytokine Growth Factor Rev 2014; 25: 257-71.10.1016/j.cytogfr.2014.04.00524856143]Search in Google Scholar
[60. Savan R, McFarland AP, Reynolds DA et al. A novel role for IL-22R1 as a driver of inflammation. Blood 2011; 117: 575-84.10.1182/blood-2010-05-285908303148120971950]Search in Google Scholar
[61. Park O, Wang H, Weng H et al. In vivo consequences of liver-specific interleukin-22 expression in mice: implications for human liver disease progression. Hepatology 2011; 54: 252-61.10.1002/hep.24339312543221465510]Search in Google Scholar
[62. Riccardi C, Santoni A, Barlozzari T, Puccetti P, Herberman RB. In vivo natural reactivity of mice against tumour cells. Int J Cancer 1980; 25: 475-486.10.1002/ijc.29102504096154658]Search in Google Scholar
[63. Wiltrout RH, Herberman RB, Zhang SR et al. Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver. J Immunol 1985; 134: 4267-4275.10.4049/jimmunol.134.6.4267]Search in Google Scholar
[64. Gorelik E, Herberman RB. Radioisotope assay for evaluation of in vivo natural cell-mediated resistance of mice to local transplantation of tumour cells. Int J Cancer 1981; 27: 709-720.10.1002/ijc.29102705197287227]Search in Google Scholar
[65. Gorelik E, Wiltrout RH, Okumura K, Habu S, Herberman RB. Role of NK cells in the control of metastatic spread and growth of tumour cells in mice. Int J Cancer 1982; 30: 107-112.10.1002/ijc.2910300118]Search in Google Scholar
[66. Jovanovic I, Radosavljevic G, Milovanovic M et al. Suppressed Innate Immune Response against Mammary Carcinoma in BALB/C Mice. Ser J Exp Clin Res 2012; 13: 55-61.10.5937/sjecr13-1706]Search in Google Scholar
[67. Standish LJ, Sweet ES, Novack J et al. Breast cancer and the immune system. J Soc Integr Oncol 2008; 6: 158-168.]Search in Google Scholar
[68. Strayer DR, Carter WA, Mayberry SD et al. Low natural cytotoxicity of peripheral blood mononuclear cells in individuals with high familial incidences of cancer. Cancer Res 1984; 44: 370-374.]Search in Google Scholar
[69. Hacene K, Desplaces A, Brunet M, Lidereau R, Bourguignat A, Oglobine J. Competitive prognostic value of clinicopathologic and bioimmunologic factors in primary breast cancer. Cancer 1986; 57: 245-250.10.1002/1097-0142(19860115)57:2<245::AID-CNCR2820570210>3.0.CO;2-2]Search in Google Scholar
[70. Mohanty I, Nayak M, Nanda BK. Cell mediated immune status in carcinoma breast. Indian J Pathol Microbiol 1991; 34: 1-6.]Search in Google Scholar
[71. Kauschke E, Komiyama K, Moro I, Eue I, König S, Cooper EL. Evidence for perforin-like activity associated with earthworm leukocytes. Zoology (Jena) 2001; 104: 13-24.10.1078/0944-2006-00002]Search in Google Scholar